AHR and hepatocellular carcinoma: Xu et al. demonstrated that in HCC cells, TDO2 facilitates the epithelial-to-mesenchymal transition (EMT) process by activating the Kyn-AhR pathway, thereby enhancing HCC metastasis and invasion [90].